MedPath

Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Skin Hyperpigmentation
Dry Skin; Eczema
Registration Number
NCT06189105
Lead Sponsor
University of Split, School of Medicine
Brief Summary

Niacinamide in lower concentrations has been recognized as a cosmetic ingredient with hydrating properties. Therefore, aim was to test the efficacy and safety of niacinamide cosmetic preparation in A Randomized, Controlled Trial.

Detailed Description

Skin hydration (as use of hydrating cosmetic ingredients) is one of the most interventions for healthy skin and skin barrier function. Therefore, cosmetic ingredients used for this purpose should be examined for their efficacy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  • healthy volunteers who gave written informed consent
Exclusion Criteria
  • skin disease, skin damage on measurement sites, use of corticosteroids and immunomodulators a month prior to the inclusion and during the trial, non-adherence to the trial protocol, exposure to artificial UV radiation, pregnancy and lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
skin oiliness assessment with sebumeter probethrough study completion, an average of 1 year

sebum level

Hydration assessment with corneometer probethrough study completion, an average of 1 year

stratum corneum hydration

TEWL assessment with Courage Khazaka probethrough study completion, an average of 1 year

Transepidermal water loss

pigmentation assessment with mexameter probethrough study completion, an average of 1 year

erythema and melanin

Secondary Outcome Measures
NameTimeMethod
subjective opinion of participantsthrough study completion, an average of 1 year

participants notes on skin rection

Trial Locations

Locations (1)

University of Split School of Medicine

🇭🇷

Split, Croatia

University of Split School of Medicine
🇭🇷Split, Croatia
Josipa Bukic
Contact
00385917933752
jbukic@mefst.hr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.